| ￥1200 | |
| A02950-50 | |
|
|
|
|
|
|
|
|
|
| Specificity | This product is specific to Cytokeratin 16 |
| Host Species | Rabbit |
| Immunogen | A synthesized peptide derived from human Cytokeratin 16 |
| Species Reactivity | Human |
| Conjugate | Unconjugated |
| Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product. | |||||||||||||
|
|||||||||||||
| Form | Liquid |
| Storage Buffer | Supplied in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol. |
| Storage Instructions | Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed. |
| Purification | Affinity-chromatography |
| Isotype | Rabbit IgG |
| Clonality | Monoclonal |
Western blot analysis of Cytokeratin 16 expression in HaCat cell lysate. »
| Target Background | Epidermis-specific type I keratin that plays a key role in skin. Acts as a regulator of innate immunity in response to skin barrier breach: required for some inflammatory checkpoint for the skin barrier maintenance. |
| Synonyms | CK-16; CK16; cytokeratin 16; Cytokeratin-16; FNEPPK; K16; K1C16; K1CP; keratin 16; Keratin-16; KRT16; KRT16A; NEPPK; |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
